Flagship Pioneering Inc. Seres Therapeutics, Inc. Call Options Transaction History
Flagship Pioneering Inc.
- $837 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MCRB
# of Institutions
94Shares Held
46.7MCall Options Held
119KPut Options Held
466K-
Vanguard Group Inc Valley Forge, PA6.29MShares$4.84 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.41MShares$1.85 Million0.21% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.78MShares$1.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$1.36 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.43MShares$1.1 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $95.5M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...